GSK plc Reports Share Transaction
Ticker: GLAXF · Form: 6-K · Filed: Jul 16, 2025 · CIK: 1131399
| Field | Detail |
|---|---|
| Company | Gsk PLC (GLAXF) |
| Form Type | 6-K |
| Filed Date | Jul 16, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: share-transaction, corporate-action, sec-filing
Related Tickers: GSK
TL;DR
GSK bought back some of its own stock on July 16, 2025.
AI Summary
GSK plc announced on July 16, 2025, that it has completed a transaction involving its own shares. The filing, a Form 6-K, details this activity as a report of a foreign private issuer.
Why It Matters
This filing indicates corporate activity related to GSK's own stock, which can be a signal to investors about the company's financial strategies or confidence.
Risk Assessment
Risk Level: low — The filing is a routine disclosure of share transactions and does not contain information suggesting significant new risks.
Key Players & Entities
- GSK plc (company) — Registrant
- July 16, 2025 (date) — Date of announcement and transaction
- 001-15170 (other) — SEC File Number
FAQ
What type of filing is this?
This is a Form 6-K, which is a Report of Foreign Private Issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934.
What is the primary subject of this filing?
The primary subject is a 'Transaction in own shares' by GSK plc.
When was this transaction announced?
GSK plc announced the transaction on July 16, 2025.
What is GSK plc's principal executive office address?
GSK plc's principal executive office is located at 79 New Oxford Street, London, WC1A 1DG.
Does GSK plc file annual reports under Form 20-F or 40-F?
Yes, GSK plc files annual reports under cover of Form 20-F.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on July 16, 2025 regarding GSK plc (GLAXF).